Total Thyroxine (T4) ELISA; REF EIA-1781
FDA Device Recall #Z-0310-2022 — Class II — October 18, 2021
Recall Summary
| Recall Number | Z-0310-2022 |
| Classification | Class II — Moderate risk |
| Date Initiated | October 18, 2021 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | DRG International, Inc. |
| Location | Springfield, NJ |
| Product Type | Devices |
| Quantity | 314 total (270 US) |
Product Description
Total Thyroxine (T4) ELISA; REF EIA-1781
Reason for Recall
Firm has identified two lots of product that do not meet product shelf life, resulting in failed Controls. The clinical impact may be a delay in diagnosis and a consumption of patient samples.
Distribution Pattern
Domestic: NY; International: TZ, VN, BD, CO, TT, YE, BO, DE, SV, GE, PY, TG, RU/UA, NI, DO, NG, EG & CM
Lot / Code Information
lot#: RN-60923 expiration date 12/31/2021; RN-60831 expiration date 12/31/2021
Other Recalls from DRG International, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2265-2025 | Class III | Brand Name: T4 Total ELISA Product Name: T4 To... | Jun 4, 2025 |
| Z-0921-2025 | Class II | DRG:HYBRiD-XL Insulin. Model/Catalog Number: HY... | Oct 7, 2024 |
| Z-0258-2025 | Class III | 17-OH Progesterone ELISA 96 well kit- An enzyme... | Sep 13, 2024 |
| Z-2622-2024 | Class III | Product Name: Salivary Testosterone ELISA Mode... | Jul 5, 2024 |
| Z-0896-2022 | Class II | C-Peptide ELISA : IVD measurement of C-Peptide ... | Dec 21, 2021 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.